Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Kirby Wallace"'
Autor:
Jesus García-López, Kirby Wallace, Joel H. Otero, Rachelle Olsen, Yong-dong Wang, David Finkelstein, Brian L. Gudenas, Jerold E. Rehg, Paul Northcott, Andrew M. Davidoff, Kevin W. Freeman
Publikováno v:
Cell Reports, Vol 30, Iss 2, Pp 454-464.e5 (2020)
Summary: Loss of heterozygosity (LOH) at 1p36 occurs in multiple cancers, including neuroblastoma (NBL). MYCN amplification and 1p36 deletions tightly correlate with markers of tumor aggressiveness in NBL. Although distal 1p36 losses associate with s
Externí odkaz:
https://doaj.org/article/239e06a48f6c4cdb89b1b7a993ab5041
Autor:
Kirby Wallace, Beeke Wienert, Christopher Bandoro, James Partridge, Craig L. Ennis, Casey D. Lalisan, Kristina Krassovsky, Gaia Andreoletti, Rajiv Sharma, Aishwarya Churi, William M. Matern, Sebastian Treusch, Jane Grogan, Daniel P. Dever
Publikováno v:
Blood. 140:12985-12986
Autor:
Kevin W. Freeman, Jerold E. Rehg, Joel H. Otero, David B. Finkelstein, Zhirong Yin, Kirby Wallace, Rachelle R. Olsen, Yong Dong Wang, Jesus Garcia-Lopez
Publikováno v:
Oncogene
Neuroblastoma (NBL) is an embryonal cancer of the sympathetic nervous system (SNS), which causes 15% of pediatric cancer deaths. High-risk NBL is characterized by N-Myc amplification and segmental chromosomal gains and losses. Owing to limited diseas
Autor:
Kevin W. Freeman, Chelsea DeVaux, Kirby Wallace, Ashton King, Jesus Garcia-Lopez, Rachelle R. Olsen, Joel H. Otero, Andrew M. Davidoff
Publikováno v:
Cancer Research. 80:B30-B30
Large segmental chromosomal alterations are common to cancer and a feature of high-risk neuroblastoma (NBL). Though they are early or initiating events in cancer, including often being found in precancerous lesions, their contribution to tumorigenesi
Autor:
Kevin W. Freeman, Yong-Dong Wang, Joel H. Otero, Rachelle R. Olsen, Jesus Garcia-Lopez, Jerold E. Rehg, David Finkelstein, Kirby Wallace
Publikováno v:
Cancer Research. 78:B19-B19
Neuroblastoma (NB) is an embryonal cancer of the sympathetic nervous system (SNS) that causes 15% of pediatric cancer deaths. A major barrier to advancing targeted therapy in NB is identifying the unknown oncogenes and tumor suppressors that are buri
Autor:
Kirby, Wallace N.
Publikováno v:
Dental Clinics of North America; July 1967, Vol. 11 Issue: 2 p399-411, 13p
Autor:
Kirby, Wallace N.
Publikováno v:
Journal of the American Dental Association; January 1962, Vol. 64 Issue: 1 p66-69, 4p